Skip to results

Consultation end date

Consultation end date

Type (1 selected)

Type

Guidance programme (1 selected)

Guidance programme

Showing 1 to 6 of 6

Guidance and quality standards in consultation
TitleConsultationTypeConsultation end date
Efgartigimod for treating generalised myasthenia gravis [ID4003]Draft guidanceTechnology appraisal guidance
Isatuximab with pomalidomide and dexamethasone for treating relapsed and refractory multiple myeloma [Review of TA658] [ID4067]Draft guidanceTechnology appraisal guidance
Setmelanotide for treating obesity and hyperphagia in Bardet-Biedl syndrome [ID3947]Draft guidanceTechnology appraisal guidance
Tafamidis for treating transthyretin amyloidosis with cardiomyopathy [ID6327]Draft guidanceTechnology appraisal guidance
Voxelotor for treating sickle cell disease [ID1403]Draft guidanceTechnology appraisal guidance
Ivosidenib with azacitidine for untreated acute myeloid leukaemia with an IDH1 R132 mutation [ID6198]Draft guidanceTechnology appraisal guidance

Results per page

  1. 10
  2. 25
  3. 50
  4. All